Articles From: EchoStar Reports Second Quarter 2014 Financial Results to Erickson Reports Second Quarter 2014 Results


ENGLEWOOD, Colo.
Sign-up for EchoStar Reports Second Quarter 2014 Financial Results investment picks
2014/8/7
The Board of Directors of Ecolab Inc. declared a regular quarterly cash dividend of $0.275 per common share, to be paid October 15, 2014, to shareholders of record at the close of business on September 16, 2014.
Sign-up for Ecolab Declares Regular Dividend investment picks
2014/8/7
Eight finalists ready to defend their dough in the next phase of Tim Hortons Duelling Donuts contest Canada NewsWire - Eight donut lovers from across Canada will travel to Tim Hortons head office to pitch their donut creation to an all-star panel of judges - OAKVILLE, ON , Aug.
Sign-up for Eight finalists ready to defend their dough in the next phase of Tim Hortons Duelling Donuts contest investment picks
2014/8/7
TEL AVIV, Israel , August 7, 2014 /PRNewswire/ -- Elbit Imaging Ltd.
Sign-up for Elbit Imaging Ltd. Announces Additional Updates to Annual General Meeting Proposals investment picks
Ellie Mae ® (NYSE:ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, announced today that it has signed a definitive agreement to acquire AllRegs, a leading information provider for the mortgage industry.
Sign-up for Ellie Mae to Acquire AllRegs investment picks
OLD GREENWICH, Conn.
Sign-up for Ellington Financial LLC Reports Estimated Book Value Per Share As Of July 31, 2014 investment picks
TEL-AVIV, Israel , August 7, 2014 /PRNewswire/ -- Ellomay Capital Ltd.
Sign-up for Ellomay Capital Ltd. Announces 2014 Annual General Meeting of Shareholders investment picks
Quarterly room nights exceed 8 million for the first time in eLong's history BEIJING , Aug.
Sign-up for eLong Reports Second Quarter 2014 Unaudited Financial Results investment picks
EMC Insurance Group Inc. (NASDAQ:EMCI): Second Quarter Ended June 30, 2014 Operating Loss Per Share – $0.04 Net Income Per Share – $0.08 Net Realized Investment Gains Per Share – $0.11 Catastrophe and Storm Losses Per Share – $1.35 Large Losses Per Share – $0.48 GAAP Combined Ratio – 109.6 percent Six Month Ended June 30, 2014 Operating Income Per Share – $0.69 Net Income Per Share – $0.87 Net Realized Investment Gains Per Share – $0.17 Catastrophe and Storm Losses Per Share – $1.71 Large Losses Per Share – $0.68 GAAP Combined Ratio – 103.9 percent 2014 Operating Income Guidance – $2.00 to $2.25 per share EMC Insurance Group Inc. (NASDAQ OMX/GS:EMCI) today reported an operating loss of $509,000 ($0.04 per share) for the second quarter ended June 30, 2014, compared to operating income
Sign-up for EMC Insurance Group Inc. Reports 2014 Second Quarter and Six Month Results investment picks
Consolidated Q3 revenue of $44.6 million Consolidated Q3 GAAP net loss of $3.2 million and non-GAAP net loss of $1.6 million Anticipate Q4 revenue of $41 to $45 million ALBUQUERQUE, N.M., Aug.
Sign-up for EMCORE Corporation Announces Financial Results for Third Quarter Ended June 30, 2014 investment picks
Emergent BioSolutions Inc. (NYSE: EBS) reported total revenue for Q2 2014 of $110.3 million as compared to $82.4 million in 2013.
Sign-up for Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2014 investment picks
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration (FDA) for Anthrax Immune Globulin Intravenous (Human) [AIGIV] as part of a development contract with the Biomedical Advanced Research and Development Authority (BARDA). AIGIV, which was acquired in the Cangene acquisition completed earlier this year, is being developed as an intravenous therapeutic treatment for inhalation anthrax.
Sign-up for Emergent BioSolutions Submits Biologics License Application to FDA for Anthrax Immune Globulin Intravenous (Human) investment picks
Emulex Corporation (NYSE:ELX), a leader in network connectivity, monitoring and management, today announced preliminary earnings results for the fourth quarter and fiscal year ending June 29, 2014.
Sign-up for Emulex Announces Preliminary Fiscal 2014 Fourth Quarter and Annual Results investment picks
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that Novartis has advanced EDP-239, Enanta’s NS5A inhibitor for hepatitis C virus (HCV), into drug combination studies with alisporivir (DEB025), a cyclophilin inhibitor being developed by Novartis.
Sign-up for Enanta Pharmaceuticals’ HCV NS5A Inhibitor EDP-239 Advances into Combination Studies with Alisporivir (DEB025) investment picks
- Acquisition Strengthens Encore's Capabilities across the Account Lifecycle; Unites Two Companies Committed to Fair and Respectful Consumer Treatment - SAN DIEGO , Aug.
Sign-up for Encore Capital Group Expands Credit Card Collections Capabilities through Purchase of Atlantic Credit & Finance investment picks
WEST LAFAYETTE, Ind., Aug.
Sign-up for Endocyte Announces Presentations at the 248th American Chemical Society National Meeting & Exposition investment picks
BURLINGTON, Mass., Aug.
Sign-up for Endurance International Group Reports 2014 Second Quarter Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961475001&sourceType=1 http://www.ccnmatthews.com/logos/20110601-enerflex.jpg CALGARY, ALBERTA --
Sign-up for Enerflex Reports Second Quarter 2014 Financial Results and Announces Quarterly Dividend investment picks
BOSTON, Aug.
Sign-up for EnerNOC Reports Results for Second Quarter of 2014 investment picks
Engility Holdings, Inc. (NYSE: EGL) today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Engility Reports Second Quarter 2014 Results investment picks
Company to Host Conference Call Today, August 7, 2014, at 11:00 AM ET ST.
Sign-up for EnteroMedics Reports Second Quarter 2014 Financial Results investment picks
2014/8/7
KENILWORTH, N.J., Aug.
Sign-up for Enterprise National Bank N.J. Announces Record Second Quarter 2014 Earnings investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961678001&sourceType=1 http://media3.marketwire.com/logos/20120320-Entreelogo.JPG VANCOUVER, BRITISH COLUMBIA --
Sign-up for Entree Gold Announces Second Quarter 2014 Results investment picks
2014/8/7
http://media.marketwire.com/attachments/201011/5080_LOGOEPICCORP.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1136172&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for EPIC Enters a Marketing and Sales Joint Venture, and Files a 15c2-11 to Trade Its Preferred Stock investment picks
2014/8/7
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that the company will present at the Wedbush Life Sciences Management Access Conference at 4:15 p.m. EDT, Tuesday, Aug.
Sign-up for EPIRUS to Present at Wedbush Life Sciences Management Access Conference investment picks
2014/8/7
Epson to Host Interactive Course on Design Tips for Digital T-Shirt Printing LONG BEACH, Calif.
Sign-up for Epson Brings Collaborative Printing Demos and Workstations to the Studio at SIGGRAPH 2014 investment picks
2014/8/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961651001&sourceType=1 http://media3.marketwire.com/logos/20140318-neweq.jpg TORONTO, ONTARIO --
Sign-up for EQ Inc. Reports Second Quarter Results investment picks
Erickson Incorporated (NASDAQ:EAC) (“Erickson,” the “Company,” “we,” “us” and “our”), a leading global provider of aviation services to a worldwide mix of commercial and government customers and the vertically integrated manufacturer and operator of the powerful, heavy-lift helicopter, the Erickson S-64 Aircrane, today announced second quarter and year to date 2014 financial results and updated its full-year guidance for fiscal 2014.
Sign-up for Erickson Reports Second Quarter 2014 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: EchoStar Reports Second Quarter 2014 Financial Results to Erickson Reports Second Quarter 2014 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices